Editas Medicine (EDIT) Q1 2024 Earnings
EDIT·Reported May 8, 2024·Before market open
Editas Medicine reported Q1 2024 revenue of $1.1M, missed analyst consensus of $7.9M by $6.8M. Diluted EPS came in at $-0.76, missed the $-0.63 consensus by $0.13.
Revenue
$1.1Mmissed by $6.8M
Consensus: $7.9MDiluted EPS
$-0.76missed by $0.13
Consensus: $-0.63
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Editas Medicine's Q1 2024 earnings report.
Editas Medicine (EDIT) reported Q1 2024 earnings on May 8, 2024 before market open.
Editas Medicine reported revenue of $1.1M and diluted EPS of $-0.76 for Q1 2024.
Revenue missed the consensus estimate of $7.9M by $6.8M. EPS missed the consensus estimate of $-0.63 by $0.13.
You can read the 10-Q periodic report (0001650664-24-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.